₹-0.93
(Market cap
₹12 Cr
Revenue (TTM)
₹27 Cr
P/E Ratio
152.3
P/B Ratio
0.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
-7.8 %
-
ROCE
-3 %
-
Industry P/E
25.64
-
EV/EBITDA
11.1
-
Debt to Equity
0.1
-
Book Value
₹28.8
-
EPS
₹0.2
-
Face value
10
-
Shares outstanding
4,440,568
10 Years Aggregate
CFO
₹10.96 Cr
EBITDA
₹17.21 Cr
Net Profit
₹4.79 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Link Pharma Chem
| -15.4 | -10.5 | 4.9 | -31.2 | -14.4 | -5.5 | 11.2 |
|
BSE Commodities*
| 6.2 | -2.2 | 16.3 | 12.0 | 16.4 | 10.6 | 15.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Link Pharma Chem
| -26.1 | -9.5 | -18.5 | 0.5 | 133.2 | 78.3 | -53.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Commodities
| 12.5 | 8.1 | 17.5 | 1.2 | 61.5 | 26.1 | -4.6 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Link Pharma Chem
|
26.1 | 11.6 | 27.4 | 0.1 | 1.7 | 0.6 | 152.3 | 0.9 |
| 1,781.5 | 9,125.5 | 1,535.9 | 180.0 | 13.9 | 12.3 | 50.7 | 6.0 | |
| 3,758.9 | 16,274.1 | 15,226.8 | 420.1 | 3.4 | 10.7 | 38.7 | 4.1 | |
| 1,602.7 | 20,296.5 | 11,506.0 | 738.8 | 11.0 | 11 | 27.5 | 2.7 | |
| 1,129.6 | 4,863.1 | 2,527.2 | 332.0 | 15.8 | 16.1 | 14.6 | 2.2 | |
| 2,004.7 | 6,850.2 | 5,248.3 | 267.4 | 6.7 | 10.5 | 25.6 | 2.5 | |
| 2,636.3 | 8,472.2 | 15,929.8 | 1,844.4 | 16.6 | 12.4 | 9.1 | 1.1 | |
| 5,059.5 | 6,850.2 | 1,995.6 | 185.3 | 11.7 | 13.8 | 37 | 4.9 | |
| 7,698.5 | 39,270.8 | 3,313.9 | 663.6 | 28.1 | 17.7 | 59.2 | 9.9 | |
| 728.4 | 18,519.5 | 14,584.0 | -1,715.0 | 4.1 | -8 | -- | 0.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Link Pharma Chem
Link Pharma Chem Limited manufactures and sells organic intermediates for pharmaceutical, agro, and specialty chemicals industries in India and internationally. It also engages in the custom synthesis/contract manufacturing for multistage synthesis... for small, medium, and large companies. The company also exports its products. The company was incorporated in 1984 and is based in Vadodara, India. Read more
-
Incorporated
1984
-
Chairman
Satish Thakur
-
Managing Director
Rishikesh Thakur
-
Headquarters
Vadodara Dist, Gujarat
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Link Pharma Chem
What is the current share price of Link Pharma Chem Ltd Today?
The share price of Link Pharma Chem Ltd is ₹26.07 (BSE) as of 23-Jun-2026 IST. Link Pharma Chem Ltd has given a return of -14.42% in the last 3 years.
What is the current PB & PE ratio of Link Pharma Chem Ltd?
The P/E ratio of Link Pharma Chem Ltd is 152.32 times as on 23-Jun-2026, a 494 premium to its peers’ median range of 25.64 times.
The P/B ratio of Link Pharma Chem Ltd is 0.91 times as on 23-Jun-2026, a 56 discount to its peers’ median range of 2.05 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
1.19
|
|
2024
|
0.00
|
1.36
|
|
2023
|
24.85
|
1.08
|
|
2022
|
9.50
|
1.23
|
|
2021
|
9.68
|
0.84
|
What is the 52 Week High and Low of Link Pharma Chem Ltd?
The 52-week high and low of Link Pharma Chem Ltd are Rs 42.80 and Rs 21.00 as of 24-Jun-2026.
What is the market cap of Link Pharma Chem Ltd?
Link Pharma Chem Ltd has a market capitalisation of ₹ 12 Cr as on 23-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Link Pharma Chem Ltd?
Before investing in Link Pharma Chem Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.